fructose-1,6-diphosphate has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Oliveira, JR; Dias, HB; Donadio, MVF; Kimura, S | 1 |
| Basso, BS; Bitencourt, S; Caberlon, E; da Silva, GV; de Mesquita, FC; de Oliveira, Fdos S; de Oliveira, JR; Ferreira, GA; Schmid, J | 1 |
2 other study(ies) available for fructose-1,6-diphosphate and Cirrhosis
| Article | Year |
|---|---|
Fructose-1,6-bisphosphate prevents pulmonary fibrosis by regulating extracellular matrix deposition and inducing phenotype reversal of lung myofibroblasts.
Topics: Animals; Bleomycin; Collagen; Disease Models, Animal; Extracellular Matrix; Fibroblasts; Fibronectins; Fibrosis; Fructose; Fructosediphosphates; Lung; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Myofibroblasts; Pulmonary Fibrosis; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1 | 2019 |
Fructose-1,6-bisphosphate induces phenotypic reversion of activated hepatic stellate cell.
Topics: Animals; Cell Line; Cell Survival; Collagen; Fibrosis; Fructosediphosphates; Hepatic Stellate Cells; Lipid Metabolism; Mice; PPAR gamma; RNA, Messenger; Transforming Growth Factor beta | 2013 |